Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS)

Chemical Research in Toxicology

Volumn 18, Issue 10, 2005, Pages 1537-1544

  Argoti, Dayana ^a   Liang, Li ^b   Conteh, Abdul ^b   Chen, Liangfu ^b   Bershas, Dave ^b   Yu, Chung Ping ^b   Vouros, Paul ^a   Yang, Eric ^b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; CIPROFLOXACIN; CLEMASTINE; CLOZAPINE; CYANIDE; GLUTATHIONE; IMINE; IMINIUM ION; INDINAVIR; KETOCONAZOLE; MIANSERIN; NEFAZODONE; NICOTINE; PHENCYCLIDINE; PROCHLORPERAZINE; RIFAMPICIN; THIORIDAZINE; TICLOPIDINE; TRIPROLIDINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; METABOLISM; NONHUMAN; RADIOMETRY; RAT; TANDEM MASS SPECTROMETRY;

AMINES; ANIMALS; CHROMATOGRAPHY, LIQUID; GLUTATHIONE; HUMANS; IMINES; MASS SPECTROMETRY; MICROSOMES, LIVER; NICOTINE; POTASSIUM CYANIDE; PROCHLORPERAZINE; RATS; TRIAZOLES;

ANIMALIA;

EID: 27144477300     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0501637     Document Type: Article

References (31)

1. Hess, D. A., and Rieder, M. J. (1997) The role of reactive drug metabolites in immune-mediated adverse drug reactions. Ann. Pharmacother. 31, 1378-1387.
2. Naisbitt, D. J., Williams, D. P., Pirmohamed, M., Kitteringham, N. R., and Park, B. K. (2001) Reactive metabolites and their role in drug reactions. Curr. Opin. Allergy Clin. Immunol. 1, 317-325.
3. Evans, D. C., Watt, A. P., Nicoll-Griffith, D. A., and Baillie, T. A. (2004) Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem. Res. Toxicol. 17, 3-16.
4. Johnson, B. M., Qiu, S. X., Zhang, S., Zhang, F., Burdette, J. E., Yu, L., Bolton, J. L., and van Breemen, R. B. (2003) Identification of novel electrophilic metabolites of Piper methysticum Forst (Kava). Chem. Res. Toxicol. 16, 733-740.
5. Johnson, B. M., and van Breemen, R. B. (2003) In vitro formation of quinoid metabolites of the dietary supplement Cimicifuga racemosa (black cohosh). Chem. Res. Toxicol. 16, 838-846.
6. Yu, L., Liu, H., Li, W., Zhang, F., Luckie, C., van Breemen, R. B., Thatcher, G. R., and Bolton, J. L. (2004) Oxidation of raloxifene to quinoids: potential toxic pathways via a diquinone methide and o-quinones. Chem. Res. Toxicol. 17, 879-888.
7. Chen, W. G., Zhang, C., Avery, M. J., and Fouda, H. G. (2001) Reactive metabolite screen for reducing candidate attrition in drug discovery. Adv. Exp. Med. Biol. 500, 521-524.
8. Castro-Perez, J., Plumb, R., Liang, L., and Yang, E. (2005) A high-throughput liquid chromatography/tandem mass spectrometry method for screening glutathione conjugates using exact mass neutral loss acquisition. Rapid Commun. Mass Spectrom. 19, 798-804.
9. Ketterer, B. (1988) Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat. Res. 202, 343-361.
10. Baillie, T. A., and Davis, M. R. (1993) Mass spectrometry in the analysis of glutathione conjugates. Biol. Mass Spectrom. 22, 319-325.
11. Grillo, M. P., Hua, F., Knutson, C. G., Ware, J. A., and Li, C. (2003) Mechanistic studies on the bioactivation of diclofenac: identification of diclofenac-S-acyl-glutathione in vitro in incubations with rat and human hepatocytes. Chem. Res. Toxicol. 16, 1410-1417.
12. Dieckhaus, C. M., Fernandez-Metzler, C. L., King, R., Krolikowski, P. H., and Baillie, T. A., (2005) Negative ion tandem mass spectrometry for the detection of glutathione conjugates. Chem. Res. Toxicol. 18, 630-638.
13. Gorrod, J. W., and Aislaitner, G. (1994) The metabolism of alicyclic amines to reactive iminium ion intermediates. Eur. J. Drug Metab. Pharmacokinet. 19, 209-217.
14. Gorrod, J. W., Whittlesea, C. M., and Lam, S. P. (1991) Trapping of reactive intermediates by incorporation of 14C-sodium cyanide during microsomal oxidation. Adv. Exp. Med. Biol. 283, 657-664.
15. Zhang, Z., Chen, Q., Li, Y., Doss, G. A., Dean, B. J., Ngui, J. S., Elipe, M. S., Kim, S., Wu, J. Y., DiNinno, F., Hammond, M. L., Stearns, R. A., Evans, D. C., Baillie, T. A., and Tang, W. (2005) In vitro bioactivation of dihydrobenzoxathiin selective estrogen receptor modulators by cytochrome P450 3A4 in human liver microsomes: formation of reactive iminium and quinone type metabolites. Chem. Res. Toxicol. 18, 675-685.
16. Hashimoto, K. (1991) Toxicology of acetonitrile. Jpn. J. Ind. Health 33, 463-474.
17. Kalgutkar, A. S., Dalvie, D. K., O'Donnell, J. P., Taylor, T. J., and Sahakian, D. C. (2002) On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics. Curr. Drug Metab. 3, 379-424.
18. Aranda-Michel, J., Koehler, A., Bejarano, P. A., Poulos, J. E., Luxon, B. A., Khan, C. M., Ee, L. C., Balistreri, W. F., and Weber, F. L., Jr. (1999) Nefazodone-induced liver failure: report of three cases. Ann. Intern. Med. 130, 285-288.
19. von Moltke, L. L., Greenblatt, D. J., Granda, B. W., Grassi, J. M., Schmider, J., Harmatz, J. S., and Shader, R. I. (1999) Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions. Psychopharmacology (Berlin) 145, 113-122.
20. Kalgutkar, A. S., Vaz, A. D. N., Lame, M. E., Henne, K. R., Soglia, J., Zhao, S. X., Abramov, Y., A., Lombardo, F., Collin, C., Hendsch, Z. S., and Hop, C. E. C. A (2005) Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450. Drug Metab. Dispos. 33, 243-253.
21. Gaertner, H. J., Breyer, U., and Liomin, G. (1974) Metabolism of trifluoperazine, fluphenazine, prochlorperazine and perphenazine in rats: in vitro and urinary metabolites. Biochem. Pharmacol. 23, 303-311.
22. McNulty, M. J., Deal, D. L., Page, T. L., Chandrasurin, P., and Findlay, J. W. (1992) Disposition of triprolidine in the male beagle dog. Drug Metab. Dispos. 20, 928-935.
23. Gangl, E., Utkin, I., Gerber, N., and Vouros, P. (2002) Structural elucidation of metabolites of ritonavir and indinavir by liquid chromatography-mass spectrometry. J. Chromatogr., A. 974, 91-101.
24. Whitehouse, L. W., Menzies, A., Dawson, B., Cyr, T. D., By, A. W., Black, D. B., and Zamecnik, J. (1994) Mouse hepatic metabolites of ketoconazole: isolation and structure elucidation. J. Pharm. Biomed. Anal. 12, 1425-1441.
25. Lambert, C., Park, B. K., and Kitteringham, N. R. (1989) Activation of mianserin and its metabolites by human liver microsomes. Biochem. Pharmacol. 38, 2853-2858.
26. Blake, B. L., Rose, R. L., Mailman, R. B., Levi, P. E., and Hodgson, E. (1995) Metabolism of thioridazine by microsomal monooxygenases: relative roles of P450 and flavin-containing monooxygenase. Xenobiotica 25, 377-393.
27. Kane, F. J., Jr., and Moore, L. P. (1971) Hepatotoxicity occurring with thioridazine therapy. South. Med. J. 64, 573.
28. Maggs, J. L., Williams, D., Pirmohamed, M., and Park, B. K. (1995) The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man. J. Pharmacol. Exp. Ther. 275, 1463-1475.
29. Pirmohamed, M., Williams, D., Madden, S., Templeton, E., and Park, B. K. (1995) Metabolism and bioactivation of clozapine by human liver in vitro. J. Pharmacol. Exp. Ther. 272, 984-990.
30. Sharma, U., Roberts, E. S., Kent, U. M., Owens, S. M., and Hollenberg, P. F. (1997) Metabolic inactivation of cytochrome P4502B1 by phencyclidine: immunochemical and radiochemical analyses of the protective effects of glutathione. Drug Metab. Dispos. 25, 243-250.
31. Ward, D. P., Trevor, A. J., Kalir, A., Adams, J. D., Baillie, T. A., and Castagnoli, N., Jr. (1982) Metabolism of phencyclidine. The role of iminium ion formation in covalent binding to rabbit microsomal protein. Drug Metab. Dispos. 10, 690-695.